Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Edgar Jannotta


Mr. Jannotta serves as a Board Member at Alcyone Lifesciences. He began his career as an associate with GTCR in 1985. After spending three years with GTCR, he left to join William Blair Capital Partners, where he was a managing director for over nine years. He rejoined GTCR in 1998 and became managing principal in 2002. Mr. Jannotta holds an AB in Politics, cum laude, from Princeton University and an MBA from Harvard University. Mr. Jannotta is a director of Graceway Pharmaceuticals, GeneraMedix Pharmaceuticals and Ovation Pharmaceuticals. In addition, Mr. Jannotta was a director and played a key role in GTCR's highly successful past investments in CuraScript and LifeCare Management Services.

Primary Investor Type
Angel (individual)
Primary Office
  • 250 Jackson Street
  • Unit 494, Mill Number 5 Building
  • Lowell, MA 01852
  • United States

+1 (781) 000-0000

Edgar Jannotta Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
00000000000 28-Jan-2016 0000 00000 00.00 Financial Software Generating Revenue 00000 00000000 00.
To view this investor’s complete investment and acquisition history, request access »
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Edgar Jannotta’s full profile, request a free trial.

Edgar Jannotta Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
00000000000 10-May-2017 0000000000 Completed
  • 3 buyers
To view this investor’s complete exits history, request access »

Edgar Jannotta Team (1)

Name Title Deals Funds Boards Office Contact
Edgar Jannotta Jr. Angel Investor 00 0 0 Lowell, MA